» Articles » PMID: 30553839

Intraductal Papillary Neoplasm of the Bile Duct: Assessment of Invasive Carcinoma and Long-term Outcomes Using MRI

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2018 Dec 17
PMID 30553839
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Imaging characteristics for discriminating the malignant potential of intraductal papillary neoplasm of the bile duct (IPNB) still remain unclear. This study aimed to define the magnetic resonance (MR) imaging findings that help to differentiate IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia and to investigate their significance with respect to long-term outcomes in patients with surgically resected IPNB.

Methods: This retrospective study included 120 patients with surgically resected IPNB who underwent preoperative MR imaging with MR cholangiography before surgery from January 2008 and December 2017 in two tertiary referral centers. Clinical and MR imaging features of IPNB with intraepithelial neoplasia (n = 34) and IPNB with an associated invasive carcinoma (n = 86) were compared. Regarding significant features for discriminating IPNB with or without an associated invasive carcinoma, recurrence-free survival (RFS) rates were evaluated.

Results: Significant MR imaging findings for differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia were intraductal visible mass, tumor size ≥2.5 cm, multiplicity of the tumor, bile duct wall thickening, and adjacent organ invasion (all p ≤0.002). The 1-, 3-, and 5-year RFS rates for surgically resected IPNB were 93.8%, 79.1%, and 70.0%, respectively. RFS rates were significantly lower in patients with each significant MR imaging finding of IPNB with an associated invasive carcinoma than in those without significant MR imaging findings (all p ≤0.039).

Conclusions: MR imaging with MR cholangiography may be helpful in differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia. Significant MR imaging findings of IPNB with an associated invasive carcinoma have a negative impact on RFS.

Lay Summary: Significant magnetic resonance imaging findings that differentiated between an intraductal papillary neoplasm of the bile duct (IPNB) with an associated invasive carcinoma and an IPNB with intraepithelial neoplasia were intraductal visible mass, tumor size ≥2.5 cm, multiplicity of the tumor, bile duct wall thickening, and adjacent organ invasion. Significant magnetic resonance imaging findings of invasive IPNB have a negative impact on recurrence-free survival.

Citing Articles

Neoplastic premalignant pancreatobiliary lesions: current update on the spectrum of lesions and their imaging appearances.

Dasyam A, Tirukkovalur N, Borhani A, Katabathina V, Singhi A, Furlan A Abdom Radiol (NY). 2025; .

PMID: 39804368 DOI: 10.1007/s00261-024-04795-7.


Prognostic factors for intraductal papillary neoplasm of the bile duct following surgical resection: a systematic review and meta-analysis.

Zeng D, Li B, Cheng N Surg Today. 2024; 55(2):131-143.

PMID: 39424711 DOI: 10.1007/s00595-024-02948-1.


Multiple intraductal papillary neoplasms of bile duct diagnosed based on endoscopic ultrasonography and peroral cholangioscopy findings.

Onoe M, Fukuba N, Kodama Y, Oka A, Kawashima K, Shibagaki K Clin J Gastroenterol. 2024; 17(5):962-969.

PMID: 38971959 PMC: 11436404. DOI: 10.1007/s12328-024-02000-2.


Intraductal papillary neoplasms of the bile ducts-what can be seen with ultrasound?.

Moller K, Braden B, Jenssen C, Ignee A, Cui X, Yamashita Y Endosc Ultrasound. 2024; 12(6):445-455.

PMID: 38948129 PMC: 11213588. DOI: 10.1097/eus.0000000000000040.


A Review of Type 1 and Type 2 Intraductal Papillary Neoplasms of the Bile Duct.

Huang X, Chen T, Liu H, Huang M Curr Med Sci. 2024; 44(3):485-493.

PMID: 38748369 DOI: 10.1007/s11596-024-2863-5.